BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2005
View Archived Issues
New data on the pharmacokinetics and metabolism of viramidine
Read More
Atorvastatin prevents autoimmune disease by interfering with Ras and Rho GTPase prenylation
Read More
EGCG exerts neuroprotective and antiinflammatory actions in murine EAE
Read More
Monoclonal antibodies prevent hepatitis C viral reinfection
Read More
GB Therapeutics changes name to Cita NeuroPharmaceuticals
Read More
Therapeutic potential of the histamine H3 receptor antagonist ABT-239
Read More
Leinamycin prodrug activated by oxidative stress in prostate tumor cells
Read More
Xsira inlicenses adenosine for reduction of postoperative pain
Read More
Target selection in Celera Genomics and Abbott collaboration
Read More
NDA resubmission for indiplon capsules
Read More
FDA ready to review OrCel PMA application
Read More
Positive findings in proof-of-principle study for COL-3 in rosacea
Read More
Genentech extends support of Curis collaborative efforts
Read More
U.K. clearance for phase IIb CoFactor study in metastatic colorectal cancer
Read More
2ME2 receives orphan drug designation for ovarian cancer
Read More
Phase I study begins dosing for intranasal RSV vaccine
Read More
Lundbeck looks back at 2004
Read More
First small-molecule agonists of orphan estrogen-related receptors synthesized
Read More
PharmaFrontiers updates recent progress
Read More
Second year of SBIR funding supports GelVac evaluation
Read More
FDA approval of Liberte stent
Read More
New treatments for diabetes claimed by Arena
Read More
Antiobesity drugs disclosed in patents from Banyu and BMS
Read More
Bionaut and AnalytiCon Discovery sign lead optimization agreement for cancer
Read More
REP-9: A highly potent broad-spectrum antiviral agent
Read More
Selective dual-specificity phosphatase inhibitors with potential as anticancer agents
Read More
Novel mechanism of antitumor activity demonstrated for NK-314
Read More